Nasreen Haque

Nasreen Haque Email and Phone Number

Founder and Chief Scientific Officer @ GENOMIC OBSERVATORY INC
Nasreen Haque's Location
New York, New York, United States, United States
Nasreen Haque's Contact Details

Nasreen Haque work email

Nasreen Haque personal email

About Nasreen Haque

Experienced scientist,educator and explorer with a demonstrated history of working in the higher education industry. Skilled in Translational Medicine, Stem Cell biology, Microbiology,Genomics / Data Analysis and Biotechnology with specialization in Inflammation/Vascular Biology. Strong education professional with a PhD focused in Biological Sciences interested in proximate and Evolutionary mechanisms of human inflammatory disorders.

Nasreen Haque's Current Company Details
GENOMIC OBSERVATORY INC

Genomic Observatory Inc

View
Founder and Chief Scientific Officer
Nasreen Haque Work Experience Details
  • Genomic Observatory Inc
    Founder And Chief Scientific Officer
    Genomic Observatory Inc Jul 2022 - Present
    Nyack, New York, United States
  • Genomic Observatory Inc
    Founder And Chief Scientific Officer
    Genomic Observatory Inc Jun 2012 - Present
    New York, Ny
    Spatiotemporal Regulation of Chemokine PolarityI am interested in understanding how the spatiotemporal organization of the chemokine system is networked with inflammatory responses to operate together and perform diverse functions that lead to chronic disorders such as atherosclerosis. As drivers of the inflammatory response, chemokine(s) and chemokine receptors mediate this process by regulating the migration of the various leukocyte subsets through diverse G protein coupled receptors [GPCRs]. We are looking at both proximate and evolutionary basis of diseases as it applies to injury, wound healing and repair. Course Director – Evolutionary Medicine in Health and DiseaseEvolutionary medicine provides an alternate way to look at health and disease. Inflammation, resistance, virulence and diseases are consequences of selective pressure and compromises incurred by organisms across evolutionary timescales. Understanding this dynamics of natural selection may help explain the complexity of human disorders. This course offers an integrated approach to study biological histories and conflicts that have shaped all life forms, by using the principles of evolution as they apply to medicine and public health. This course will address the elements of evolutionary theory, interpretation of data in relation to specific hypotheses, major human infectious, chronic, and genetic diseases, in an evolutionary perspective.
  • City University Of New York (Cuny
    Assistant Professor
    City University Of New York (Cuny Sep 2006 - Present
  • New York Medical College
    Associate Professor
    New York Medical College Jun 2012 - Jul 2022
    United States
  • Barnard College,Columbia University
    Term Assistant Professor
    Barnard College,Columbia University Aug 2004 - Sep 2005
    Greater New York City Area
    Assistant Professor of BiochemistryIdentified the role of CC Chemokine CCL-1 responsive gene expression profile in human HeLa cells
  • Mount Sinai School Of Medicine
    Research Assistant Professor
    Mount Sinai School Of Medicine Aug 2003 - Aug 2004
    Greater New York City Area
    Show that that CC chemokine receptor CCR8 mediates human vascular smooth muscle cells (VSMCs) chemotaxis and matrix mettaloprotein- 2 [MMP-2] secretion. The induction of CCR8 and CCL1/TCA3 under conditions associated with VSMC proliferation and migration raises the possibility that CCR8 may play an important role in vessel wall pathology.
  • Mount Sinai School Of Medicine
    Instructor
    Mount Sinai School Of Medicine Jul 2002 - Jul 2004
    Identified CC Chemokine CCL1 and CCR-8 in Kaposi sarcoma showing that CCR8 may modulate endothelial function : Identified CCR8 and I-309 (CCL1) on the endothelium of human atherosclerotic plaques and in endothelial-derived spindle cells of Kaposi sarcoma. Developed transgenic and knockout animal mouse models: Role of CCR8 during vascular injury were studied on mouse models subjected to injury of femoral artery. Development of inhibitors: (i) Monoclonal antibodies against the chemokine receptor CCR8; (ii)Designed and characterized chemokine specific siRNA and (iii) Established CCR8 deficient cell lines.
  • Mount Sinai School Of Medicine
    Research Associate
    Mount Sinai School Of Medicine Aug 1997 - Jul 2002
    Identified CC chemokine I-309 ( CCL1 ) as a major chemoattractant in Lipoprotein(a) [Lp[a)] mediated atherosclerosis : Human endothelial cells treated with Lipoprotein (a) result in the expression of a chemokine I-309 (CCL1) This resulted in the funding of an NIH RO1 grant.Lab Head : Peter Harpel,MD/PhD
  • Memorial Sloan-Kettering Cancer Center
    Research Fellow
    Memorial Sloan-Kettering Cancer Center Jun 1996 - Jun 1997
    New York
    Determined how the regulation of transcription factor AP - 1 activity is mediated by AML / ETO : The t (8;21) translocation is the most frequent genetic abnormality associated with acute myelogenesis leukemia. Based on the hypothesis that AML and AML / ETO function as transcription regulators of certain genes which in turn trigger signal pathways leading to changes in AP- 1 activity, we found that AML / ETO fusion protein raises activity in MLA 144 cells and the zinc finger motif is required for this activity. Supervisor : Stephen D. Nimer, MD/PhD
  • Thomas Jefferson University
    Post Doctoral Fellow
    Thomas Jefferson University Aug 1990 - Jun 1995
    Isolated and characterized Myelin Regulatory factor ( MRF - 1) : Isolation of a novel cDNA myelin regulatory factor - 1 was derived from a mouse brain expression library which has 97% homology with the previously identified splicing factor SC35.MRF-1; increases transcription of the MBP promoter in glial cells and this activation requires an intact MRF – 1 binding site within the MB3 region. Identified a distal cis - acting regulatory element in myelin basic protein gene promoter : Identified the G residues located between -93 to -130 nucleotides with respect to the RNA start site in the myelin basic protein gene and contains a binding site for the NF1 / CTF family of transcription are important to confirm transcriptional activity to this domain in transiently transfected glial cells.  Determined the expression of myelin basic protein (MBP) in transgenic mice expressing human neurotropic virus, JCV : Programmed expression of JCV T-antigen, which overlaps the MBP gene transcription at early stages of myelination, suggests the involvement of a pathway which modulates stage specific regulation of myelin genes and viral gene expression in transgenic mice during brain development. Supervisor : Kamel S. Khalili,Ph.D
  • Nii - National Institute Of Immunology
    Scientific Officer
    Nii - National Institute Of Immunology Jun 1987 - Jun 1989
    Developed the fist transgenic fish in India and accomplished our objective of integrating the foreign growth hormone gene in Indian major carp Labeo rohita genome. Established a aquaculture station at Dhauj, India for all field work related to the project.Collaborators: Dr Jaspal S. Khillan, Prof. PG Talwar Funding Source: Department of Biotechnology, Government of India
  • National Institute Of Oceonography,Goa,India
    Research Associate
    National Institute Of Oceonography,Goa,India Jul 1986 - Jun 1987
    Expedition aboard NIO research Vessel Gavashini to Laccadive islands led to the identification of fish species from Laccadive Island which added to the existing knowledge of fish collection on the island. Expedition Leader : Dr. MVM Wafar,NIOFunding : Department of Ocean Development, Government of India.

Nasreen Haque Skills

Biochemistry Biotechnology Cell Genetics Cell Culture Biology Data Analysis Animal Models Clinical Research Community Outreach Curriculum Development Drug Discovery Field Work Entrepreneurship Research

Nasreen Haque Education Details

Frequently Asked Questions about Nasreen Haque

What company does Nasreen Haque work for?

Nasreen Haque works for Genomic Observatory Inc

What is Nasreen Haque's role at the current company?

Nasreen Haque's current role is Founder and Chief Scientific Officer.

What is Nasreen Haque's email address?

Nasreen Haque's email address is na****@****hoo.com

What schools did Nasreen Haque attend?

Nasreen Haque attended Aligarh Muslim University.

What skills is Nasreen Haque known for?

Nasreen Haque has skills like Biochemistry, Biotechnology, Cell, Genetics, Cell Culture, Biology, Data Analysis, Animal Models, Clinical Research, Community Outreach, Curriculum Development, Drug Discovery.

Not the Nasreen Haque you were looking for?

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.